Quick Answer
RxSight, Inc. reported Shares Outstanding of 41.24 million shares for fiscal year 2025.
RxSight, Inc. Shares Outstanding — Annual History
| Fiscal Year | Shares Outstanding | YoY Change |
|---|---|---|
| 2025 | 41.24M | +2.0% |
| 2024 | 40.43M | +11.9% |
| 2023 | 36.14M | +27.8% |
| 2022 | 28.27M | +3.3% |
| 2021 | 27.37M | — |
Quarterly Shares Outstanding
| Quarter Ending | Shares Outstanding | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | 41.08M | +2.1% | +0.4% |
| June 30, 2025 | 40.91M | +3.3% | +0.8% |
| March 31, 2025 | 40.59M | +9.2% | +0.4% |
| December 31, 2024 | 40.43M | +11.9% | +0.4% |
| September 30, 2024 | 40.25M | +12.3% | +1.6% |
| June 30, 2024 | 39.62M | +12.7% | +6.6% |
| March 31, 2024 | 37.16M | +9.4% | +2.8% |
| December 31, 2023 | 36.14M | +27.8% | +0.8% |
- RxSight, Inc. showed an increase of +2.0% in Shares Outstanding compared to the prior fiscal year.
- Over the 2021–2025 period, RxSight, Inc.’s shares outstanding has grown by 50.7% (from 27.37 million shares to 41.24 million shares).
- The most recent figure is from RxSight, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 25, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: